Abstracts tagged "Spondylarthritis"

Abstract Number: 541 • 2014 ACR/ARHP Annual Meeting
Collagen II Neo-Epitopes in Spondyloarthritis.
Heidi Lausten Munk¹, Natasja Staehr Gudmann², Anne Friesgaard Christensen³, Leif Ejstrup⁴, Grith Lykke Sørensen⁵, Anne Gitte Loft³, Anne C. Bay-Jensen², Anne Sofie Siebuhr² and Peter Junker¹, ¹Department of Rheumatology, Odense University Hospital, Odense, Denmark, ²Cartilage Biomarkers and Research, Nordic Bioscience, Herlev, Denmark, ³Department of Rheumatology, Vejle Hospital, Vejle, Denmark, ⁴Department of Rheumatology, Esbjerg Hospital, Esbjerg, Denmark, ⁵Cardiovascular and Renal Research, Institute of Molecular Medicin, University of Southern Denmark, Odense, Denmark
Background/Purpose Spondyloarthritis (SpA) is characterized by aseptic inflammation of the axial skeleton which may ultimately lead to irreversible deformities due to bony ankylosis. Occasionally, peripheral…
Abstract Number: 2777 • 2013 ACR/ARHP Annual Meeting
Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: Part of a Common Spectrum Or Distinct Diseases? Analysis of a Longitudinal Prospective Cohort
Dinny Wallis¹, Nigil Haroon¹, Renise Ayearst², Adele Carty¹ and Robert D. Inman³, ¹Rheumatology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, ²Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ³Toronto Western Hospital, University of Toronto, Toronto, ON, Canada
Ankylosing spondylitis and non-radiographic axial spondyloarthritis: part of a common spectrum or distinct diseases? Analysis of a longitudinal prospective cohort. Background/Purpose: Historically ankylosing spondylitis…
Abstract Number: 2452 • 2013 ACR/ARHP Annual Meeting
Effects Of Smoking In Patients With Axial Spondyloarthritis – Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis – Receiving Anti-TNF therapy
Ozlem Pehlivan, Yasemin Yalcinkaya, Nihat Huseyinsinoglu, Nilufer Alpay Kanitez, Burak Erer, Sevil Kamali, Murat Inanç, Orhan Aral, Ahmet Gul and Lale Ocal, Department of Internal Medicine, Rheumatology Division, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
Background/Purpose: Ankylosing spondylitis (AS) is a systemic disease characterized by sacroiliitis and inflammatory back pain. The radiological findings of AS appear late causing delay in…
Abstract Number: 1536 • 2013 ACR/ARHP Annual Meeting
Do Patients With Ankylosing Spondylitis Have An Excess Prevalence Of Chronic Widespread PAIN?: Results From The Scotland and Ireland Registry For Ankylosing Spondylitis (SIRAS) and The Musician Study
Fabiola Azeni^1,2, Marcus Beasley¹, Linda E. Dean¹, Gareth T Jones³, Jane Gibson⁴, Piercarlo Sarzi-Puttini⁵ and Gary J. Macfarlane on behalf of SIRAS and MUSICIAN study investigators¹, ¹Musculoskeletal Research Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, ²Rheumatology Unit, L.Sacco University Hospital, Milan, Italy, ³Musculoskeletal Research Collaboration (Epidemiology Group),, University of Aberdeen, Aberdeen, United Kingdom, ⁴NHS Fife, Fife Rheumatic Diseases Unit, Kircaldy, United Kingdom, ⁵Rheumatology Unit, L. Sacco University Hospital, Milan, Italy
Background/Purpose: To determine whether there is an excess prevalence of chronic widespread body pain (CWP) in patients with Ankylosing spondylitis (AS). Methods: Patients were…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].